CorNeat Vision

Founded: 2015 • Age: 11 yrs
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
Request Access

About CorNeat Vision

CorNeat Vision is a company founded in 2015 by Gilad Litvin.. CorNeat Vision has raised $4 million across 3 funding rounds from investors including European Union, GIBF and EIC Fund. CorNeat Vision offers products and services including CorNeat KPro, eShunt, and EverPatch+. CorNeat Vision operates in a competitive market with competitors including CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others.

  • Founders Gilad Litvin
  • Sectors
    Technology
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Technology → Quantum & Emerging Technologies
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4 M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.73 M (USD), Grant

    Feb 01, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CorNeat Vision

CorNeat Vision offers a comprehensive portfolio of products and services, including CorNeat KPro, eShunt, and EverPatch+. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Implant for treating corneal blindness by integrating with eye tissue.

Minimally invasive drainage device for glaucoma surgery.

Permanent matrix for reinforcing ocular surfaces and repairs.

Funding Insights of CorNeat Vision

CorNeat Vision has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.73 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $2.7M
  • First Round

    (01 Jun 2021)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2022 Amount Grant - CorNeat Vision Valuation

investors

Aug, 2021 Amount Series A - CorNeat Vision Valuation GIBF
Jun, 2021 Amount Grant - CorNeat Vision Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CorNeat Vision

CorNeat Vision has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, GIBF and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CorNeat Vision

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CorNeat Vision

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Corneat Vision Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CorNeat Vision

CorNeat Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for corneal transplants are developed by CorneaGen.
domain founded_year HQ Location
Proprietary implantable satellite organs are developed for cell therapy.
domain founded_year HQ Location
Corneal collagen cross-linking technology is developed for ophthalmic applications.
domain founded_year HQ Location
Therapeutics and drug delivery systems for eye diseases are developed.
domain founded_year HQ Location
Nanotechnology-based red blood cell substitutes are developed.
domain founded_year HQ Location
iPS cell-based technology for corneal endothelium regeneration is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Corneat Vision

Frequently Asked Questions about CorNeat Vision

When was CorNeat Vision founded?

CorNeat Vision was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Who is the current CEO of CorNeat Vision?

Almog Aley raz is the current CEO of CorNeat Vision.

Is CorNeat Vision a funded company?

CorNeat Vision is a funded company, having raised a total of $4M across 3 funding rounds to date. The company's 1st funding round was a Grant of $56.63K, raised on Jun 01, 2021.

What does CorNeat Vision do?

CorNeat Vision was founded in 2015 as a developer of nanotechnology-based artificial corneal implants. Nano-cell technology is employed in these synthetic corneas, which can be integrated with artificial optics. The product line, including CorNeat KPro and CorNeat EverPatch, is designed for ophthalmic surgeries addressing cornea, sclera, glaucoma trabecular mesh, myopia, and related areas. Operations focus on medical device innovation in the biotechnology sector.

Who are the top competitors of CorNeat Vision?

CorNeat Vision's top competitors include CorneaGen, EyeYon and KaloCyte.

What products or services does CorNeat Vision offer?

CorNeat Vision offers CorNeat KPro, eShunt, and EverPatch+.

Who are CorNeat Vision's investors?

CorNeat Vision has 3 investors. Key investors include European Union, GIBF, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available